Vaccinex (VCNX) Competitors $1.03 -0.09 (-8.04%) As of 02/21/2025 01:31 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends VCNX vs. AYTU, CYCN, CELZ, AIM, DWTX, INDP, NLSP, CNSP, NEUP, and ADXNShould you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Aytu BioPharma (AYTU), Cyclerion Therapeutics (CYCN), Creative Medical Technology (CELZ), AIM ImmunoTech (AIM), Dogwood Therapeutics (DWTX), Indaptus Therapeutics (INDP), NLS Pharmaceutics (NLSP), CNS Pharmaceuticals (CNSP), Neuphoria Therapeutics Inc. - Common Stock (NEUP), and Addex Therapeutics (ADXN). These companies are all part of the "pharmaceutical products" industry. Vaccinex vs. Aytu BioPharma Cyclerion Therapeutics Creative Medical Technology AIM ImmunoTech Dogwood Therapeutics Indaptus Therapeutics NLS Pharmaceutics CNS Pharmaceuticals Neuphoria Therapeutics Inc. - Common Stock Addex Therapeutics Vaccinex (NASDAQ:VCNX) and Aytu BioPharma (NASDAQ:AYTU) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, community ranking, valuation, analyst recommendations and dividends. Does the media prefer VCNX or AYTU? In the previous week, Vaccinex's average media sentiment score of 0.00 equaled Aytu BioPharma'saverage media sentiment score. Company Overall Sentiment Vaccinex Neutral Aytu BioPharma Neutral Which has stronger earnings and valuation, VCNX or AYTU? Aytu BioPharma has higher revenue and earnings than Vaccinex. Aytu BioPharma is trading at a lower price-to-earnings ratio than Vaccinex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccinex$388K6.90-$20.25M-$48.27-0.02Aytu BioPharma$81M0.10-$15.84M-$1.45-0.93 Do institutionals and insiders believe in VCNX or AYTU? 50.1% of Vaccinex shares are owned by institutional investors. Comparatively, 33.5% of Aytu BioPharma shares are owned by institutional investors. 51.5% of Vaccinex shares are owned by insiders. Comparatively, 2.8% of Aytu BioPharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in VCNX or AYTU? Aytu BioPharma received 132 more outperform votes than Vaccinex when rated by MarketBeat users. Likewise, 67.11% of users gave Aytu BioPharma an outperform vote while only 60.00% of users gave Vaccinex an outperform vote. CompanyUnderperformOutperformVaccinexOutperform Votes12360.00% Underperform Votes8240.00% Aytu BioPharmaOutperform Votes25567.11% Underperform Votes12532.89% Which has more volatility & risk, VCNX or AYTU? Vaccinex has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Aytu BioPharma has a beta of -1.45, meaning that its share price is 245% less volatile than the S&P 500. Is VCNX or AYTU more profitable? Vaccinex has a net margin of 0.00% compared to Aytu BioPharma's net margin of -7.62%. Vaccinex's return on equity of 0.00% beat Aytu BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets VaccinexN/A N/A -383.58% Aytu BioPharma -7.62%-19.30%-4.80% SummaryVaccinex beats Aytu BioPharma on 7 of the 13 factors compared between the two stocks. Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCNX vs. The Competition Export to ExcelMetricVaccinexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.68M$7.07B$5.84B$9.15BDividend YieldN/A2.75%4.75%3.85%P/E Ratio-0.025.4725.4719.00Price / Sales6.90306.08447.5876.30Price / CashN/A65.6738.0134.83Price / Book-0.406.717.644.62Net Income-$20.25M$138.33M$3.18B$245.85M7 Day Performance18.79%-2.61%-1.99%-2.68%1 Month Performance-14.88%-2.32%-0.42%-2.19%1 Year Performance-87.04%-5.31%16.51%12.84% Vaccinex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCNXVaccinexN/A$1.03-8.0%N/A-88.4%$2.68M$388,000.00-0.0240Gap DownAYTUAytu BioPharma1.0333 of 5 stars$1.39+0.4%N/A-55.0%$8.52M$81M-1.13160High Trading VolumeCYCNCyclerion Therapeutics0.7851 of 5 stars$3.12+3.0%N/A-1.1%$8.46M$1.62M0.0030CELZCreative Medical Technology0.8967 of 5 stars$4.74+3.3%N/A+28.0%$8.30M$10,000.00-1.255Gap DownHigh Trading VolumeAIMAIM ImmunoTech1.9945 of 5 stars$0.13-6.9%$2.75+2,031.8%-67.1%$8.23M$200,000.00-0.2720High Trading VolumeDWTXDogwood TherapeuticsN/A$6.13-8.6%N/AN/A$8.15MN/A-0.945Gap DownINDPIndaptus Therapeutics3.1124 of 5 stars$0.80+2.1%$8.50+963.8%-52.9%$8.15MN/A-0.476Gap UpNLSPNLS PharmaceuticsN/A$2.26-1.7%N/A+364.1%$8.14MN/A0.006Gap UpCNSPCNS Pharmaceuticals3.4724 of 5 stars$0.14+29.9%$0.50+257.1%-99.5%$8.05MN/A0.005Stock SplitNews CoverageGap UpHigh Trading VolumeNEUPNeuphoria Therapeutics Inc. - Common Stock2.2867 of 5 stars$4.94+7.4%$21.00+325.1%N/A$8.05M$10,000.000.00N/AEarnings ReportADXNAddex Therapeutics2.5252 of 5 stars$7.50+6.2%$30.00+300.3%-25.0%$7.95M$1.83M-22.0430 Related Companies and Tools Related Companies AYTU Competitors CYCN Competitors CELZ Competitors AIM Competitors DWTX Competitors INDP Competitors NLSP Competitors CNSP Competitors NEUP Competitors ADXN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VCNX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VCNX Stock Alerts